Patent ID: 11858922
Assignee: THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 31:
32. A prodrug of a compound, or a pharmaceutically acceptable salt or solvate thereof, wherein the compound is a compound of formula (II) or (III), or a pharmaceutically acceptable salt or solvate thereof:, wherein:
W2 and R2 form an indacene group or a substituted or hydrogenated variant thereof; and
(R1)2N— in formula (II) or A in formula (III) is selected from the group consisting of:, wherein:
each dashed line may independently be a bond;
T is O or S;
A, B, D, E, W, X, Y and Z, when present, are each independently selected from O, C(R3), C(R3)2, N, N(R3) and S;
each incidence of R3 is independently selected from the group consisting of hydrogen, halide, cyano, C1-C6 alkyl, C1-C6 trifluoroalkyl, C1-C6 alkoxy, C═O, SO2, acyl, amino, hydroxyl, C5-C6 heteroaryl, C5-C6 heterocyclyl and C3-C6 cycloalkyl, each of which may be optionally substituted; and
n is 0, 1, 2 or 3.